These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 18344521)
1. Sensitive Melting Analysis after Real Time- Methylation Specific PCR (SMART-MSP): high-throughput and probe-free quantitative DNA methylation detection. Kristensen LS; Mikeska T; Krypuy M; Dobrovic A Nucleic Acids Res; 2008 Apr; 36(7):e42. PubMed ID: 18344521 [TBL] [Abstract][Full Text] [Related]
2. Quality assessment of DNA derived from up to 30 years old formalin fixed paraffin embedded (FFPE) tissue for PCR-based methylation analysis using SMART-MSP and MS-HRM. Kristensen LS; Wojdacz TK; Thestrup BB; Wiuf C; Hager H; Hansen LL BMC Cancer; 2009 Dec; 9():453. PubMed ID: 20025721 [TBL] [Abstract][Full Text] [Related]
3. Nested multigene MSP/DHPLC method for analyzing promoter hypermethylation status in clinical samples. Divine KK; Liechty KC; Crume KC; Belinsky SA Biotechniques; 2006 Jan; 40(1):40, 42, 44 passim. PubMed ID: 16454038 [No Abstract] [Full Text] [Related]
4. Frequent but borderline methylation of p16 (INK4a) and TIMP3 in medulloblastoma and sPNET revealed by quantitative analyses. Mühlisch J; Bajanowski T; Rickert CH; Roggendorf W; Würthwein G; Jürgens H; Frühwald MC J Neurooncol; 2007 May; 83(1):17-29. PubMed ID: 17206475 [TBL] [Abstract][Full Text] [Related]
5. Closed-tube PCR methods for locus-specific DNA methylation analysis. Candiloro IL; Mikeska T; Dobrovic A Methods Mol Biol; 2011; 791():55-71. PubMed ID: 21913071 [TBL] [Abstract][Full Text] [Related]
6. Assessing combined methylation-sensitive high resolution melting and pyrosequencing for the analysis of heterogeneous DNA methylation. Candiloro IL; Mikeska T; Dobrovic A Epigenetics; 2011 Apr; 6(4):500-7. PubMed ID: 21364322 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic alterations by methylation of RASSF1A and DAPK1 promoter sequences in mammary carcinoma detected in extracellular tumor DNA. Ahmed IA; Pusch CM; Hamed T; Rashad H; Idris A; El-Fadle AA; Blin N Cancer Genet Cytogenet; 2010 Jun; 199(2):96-100. PubMed ID: 20471512 [TBL] [Abstract][Full Text] [Related]
8. Methylation profile of genes CDKN2A (p14 and p16), DAPK1, CDH1, and ADAM23 in head and neck cancer. Calmon MF; Colombo J; Carvalho F; Souza FP; Filho JF; Fukuyama EE; Camargo AA; Caballero OL; Tajara EH; Cordeiro JA; Rahal P Cancer Genet Cytogenet; 2007 Feb; 173(1):31-7. PubMed ID: 17284367 [TBL] [Abstract][Full Text] [Related]
9. High-resolution melting-based quantitative analysis of RASSF1 methylation in breast cancer. Stuopelytė K; Daniūnaitė K; Laurinavičienė A; Ostapenko V; Jarmalaitė S Medicina (Kaunas); 2013; 49(2):78-83. PubMed ID: 23888343 [TBL] [Abstract][Full Text] [Related]
10. Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation. Wojdacz TK; Dobrovic A Nucleic Acids Res; 2007; 35(6):e41. PubMed ID: 17289753 [TBL] [Abstract][Full Text] [Related]
11. Patterns of gene promoter methylation in squamous cell cancer of the head and neck. Hasegawa M; Nelson HH; Peters E; Ringstrom E; Posner M; Kelsey KT Oncogene; 2002 Jun; 21(27):4231-6. PubMed ID: 12082610 [TBL] [Abstract][Full Text] [Related]
12. A 115-bp MethyLight assay for detection of p16 (CDKN2A) methylation as a diagnostic biomarker in human tissues. Zhou J; Cao J; Lu Z; Liu H; Deng D BMC Med Genet; 2011 May; 12():67. PubMed ID: 21569495 [TBL] [Abstract][Full Text] [Related]
13. Methylation of the p16(Ink4a) tumor suppressor gene 5'-CpG island in breast cancer. Nielsen NH; Roos G; Emdin SO; Landberg G Cancer Lett; 2001 Feb; 163(1):59-69. PubMed ID: 11163109 [TBL] [Abstract][Full Text] [Related]
14. Development and application of a multiplex PCR procedure for the detection of DNA methylation in colorectal cancer. Anacleto C; Rossi B; Lopes A; Soares FA; Rocha JC; Caballero O; Camargo AA; Simpson AJ; Pena SD Oncol Rep; 2005 Feb; 13(2):325-8. PubMed ID: 15643519 [TBL] [Abstract][Full Text] [Related]
16. Association of aberrant DNA methylation with clinicopathological features in breast cancer. Tserga A; Michalopoulos NV; Levidou G; Korkolopoulou P; Zografos G; Patsouris E; Saetta AA Oncol Rep; 2012 May; 27(5):1630-8. PubMed ID: 22159596 [TBL] [Abstract][Full Text] [Related]
17. A closed-tube methylation-sensitive high resolution melting assay (MS-HRMA) for the semi-quantitative determination of CST6 promoter methylation in clinical samples. Dimitrakopoulos L; Vorkas PA; Georgoulias V; Lianidou ES BMC Cancer; 2012 Oct; 12():486. PubMed ID: 23088560 [TBL] [Abstract][Full Text] [Related]
18. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Rosas SL; Koch W; da Costa Carvalho MG; Wu L; Califano J; Westra W; Jen J; Sidransky D Cancer Res; 2001 Feb; 61(3):939-42. PubMed ID: 11221887 [TBL] [Abstract][Full Text] [Related]
19. High-Resolution Melting (HRM) analysis of DNA methylation using semiconductor chip-based digital PCR. Jeong J; Yang Y; Song MS; Won HY; Han AT; Kim S Genes Genomics; 2024 Aug; 46(8):909-915. PubMed ID: 38849705 [TBL] [Abstract][Full Text] [Related]
20. PCR-based methods for detecting single-locus DNA methylation biomarkers in cancer diagnostics, prognostics, and response to treatment. Kristensen LS; Hansen LL Clin Chem; 2009 Aug; 55(8):1471-83. PubMed ID: 19520761 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]